| 1 | Arendorf 198513 | Prospective | Exp: 33 (15/18) | 8–17 y | ROA | Six mucosal site (ant and post palate, ant and post tongue, r and l cheek) | T0 = before AppInsT1 = during therapyT2 = after AppRem (after average 9 mos) | Imprint Culture (Arendorf and Walker technique) | Prevalence (%) Density | PI + saliv pH | C |
| 2 | Hägg 200414 | Prospective | Exp: 27 (13/14) | 15.5 + 2.3 y | FOA | Rinse Dorsum of the tongue Supra and subgingival plaque | T0=before AppInsT1 = 1 mos after T0T2 = 2 mos after T0T3 = 3 mos after T0 | Oral Rinse (Samaranayake technique) Imprint Culture (Arendorf and Walker technique) (SDA, Gram stain, germ tube test, API 20 C AUX) Pooled Plaque | Prevalence (%)Density (CFU)Species composition | PI + count of Enterobacteriaceae + total bacterial count | B |
| 3 | Arslan 200815 | Prospective | Exp 1: 72Exp 2: 42 (19/23) Candida carriers out of 72 subjects, that were treated | 19.8 y | FOA (metal brackets) | Dorsum of the tongue (only for T0)Mid-palate (only for T0)SalivaU5/L5U1/L1 | T0 = before AppInsT1 = 1 mos after T0T2 = 6 mos after T0T3 = 12 mos after T0 | Swab Culture (Kleinegger method, SDA)Salivary culture (SDA, Gram staining, germ-tube test, chlamydospore, API 20C AUX system))Pooled plaque (SDA) | Prevalence (%)Density (CFU)Species composition | None | B |
| 4 | Lee 200816 | Prospective | Exp: 97 (38/59) | 17.7 y | FOA | Rinse | From T0 = before AppIns to T10 = 12 mos after T0 | Oral rinse technique (Samaranayake technique, SDA)Phenotypic methods (germ-tube test; API ID 32C)Genotypic methods (RAPD analysis)Dendogram analysis | Prevalence (%)Species composition | None | C |
| 5 | Mahmoudadabi 200917 | Prospective | Exp 1: 34Exp 2: 34 | 13 y (Exp 1)12.5 y (Exp 2) | ROA (upper) Cr | Saliva Surface of upper appliance (not considered) | T0 = before AppInsT1 = over 8 mos after T0 | Culture (Arendorf and Walker, Davenport techiques) (CHROMagar; germ-tube test) | Prevalence (%)Count (CFU)Species composition | None | C |
| 6 | Gonçalves e Silva 201418 | Prospective | Exp 1: 30Exp 2: 30 | 9.1+−1.7 (Exp 1)7.7+−1.5 (Exp 2) | ROA Cr | Cheek and lateral surface of the tongue Saliva | T0 = before AppInsT1 = at least 6 mos after T0 | Culture (SDA; CHROMagar) Phenotypic methods Exfoliative cytology | Prevalence (%)Count (CFU)Species composition | Counts of Anti-C.albicansIgA | B |
| 7 | Arab 20168 | Prospective | Exp 1: 30 (6/24) | 12–18 y | FOA | Saliva | T0 = before AppInsT1 = 6 we after T0T2 = 12 we after T0T3 = 18 we after T0 | Culture (SDA) | Count (CFU) | Salivary flow and pH Microbial counts (S. mutans/L. acidophilus) | C |
| 8 | Khanpayeh 201419 | Prospective | Exp 1: 40Exp 2: 40 (35/45) | 7–18 y | FOA (metal) ROA | Unstimulated saliva | T0 = before AppInsT1 = 6 mos after T0 | Culture (SDA; Germ-tube test; corn meal agar)Biochemical tests (API 20C method) | Frequency (%)Species composition | None | B |
| 9 | Kundu 201620 | Prospective | Exp 1: 10Exp 2: 10 (not considered) | 6–15 y | ROA Fixed space maintainers (nc) | Unstimulated saliva | T0 = before AppInsT1 = 1 mo after T0T2 = 3 mos after T0T3 = 6 mos after T0 | Culture (SDA) | Count (CFU) | Bacterial count (S. mutans and Lactobacillussp.) | B |
| 10 | Zheng 201621 | Prospective | Exp 1: 50 (23/27) | 10–18 (13.6 y) | FOA | Gargle | T0 = before AppInsT1 = 1 mo after T0T2 = 2 mos after T0T3 = 3 mos after T0T4 = 6 mos after T0 | Culture (CHROMagar)PCR (Tiangen Biotech) | Incidence (%)Count (CFU)Species composition | None | B |
| 11 | Shukla 201722 | Prospective | Exp 1: 60 | 16–18 y | FOA | Buccal and labial Plaque of anterior teeth and U6 + L6 | T0 = before AppInsT1 = 2 mo after T0T2 = 3 mos after T0 | Swab Culture (SDA; Gram stain; germ tube test, counts in CFU) | Count (CFU) | S. mutans | B |
| 12 | Grzegocka 202023 | Prospective | Exp 1: 17 (6M/11) | 17+−7 y | FOA | Oral rinse Elastomeric rings (nc) | T0 = before AppInsT1 = 2 we after T0T2 = 6 we after T0T3 = 12 we after T0 | Culture (Dalmau plate technique)Biochemical tests (API 20C AUX) | Prevalence (%)Count(CFU) Species composition | APIGBIBiofilm formation | C |
| 13 | Sanz-Orrio-Soler 202024 | Prospective Controlled Trial | Exp 1: 124 (43/80) | 19.5 y | FOA (metal or ceramic) | U and L vestibule | T0 = before AppInsT1 = 1 mo after T0T2 = 6 mos after T0T3 = 12 mos after T0T4 = 6 mos after | Swab Culture (CHROMagar plates, Becton Dickinson) | Frequency (%)Species composition | Questionnaire about hygiene habits | B |
| 14 | Pellissari 202125 | Prospective | Exp 1: 23 (7/10)Exp 2: 6 (2/4) | 20.7+− 8.7 y (Exp 1)19.6+−1.3 y (Exp 2) | FOACr | Biofilm around bck | From 3 to 6 mos after AppIns | Culture Biochemical tests (VITEK 2 compact system) | Prevalence (%)Species composition | Fungal strains and resistance to Antifungals Bacterial strains and resistance to Antimicrobials | B |
| 15 | Rodríguez Rentería 202126 | Prospective | Exp 1: 55 (34/21) | 8.4 y | ROA | Support oral mucosa Surface of ROA (not considered) | T0 = before AppInsT1 = 4 we after T0 | Chromogenic culture (ID 32 C AUX system) | Frequency (%)Species composition | Microbial species (Str.aureus, P.aeruginosa) | C |
| 16 | Kouvelis 202127 | Prospective | Exp 1: 30 (17/13) | 13.97 +− 2.07 | FOA | Saliva | T0 = before AppInsT1 = 4 we after T0T1 = 12 we after T0 | Culture | Count | Salivary pH, flow rate, buffering capacityOther microbial species | C |